CRNX - Crinetics Pharmaceuticals prices $350.0 million upsized stock offering
2023-09-13 06:45:06 ET
More on Crinetics Pharmaceuticals
- Seeking Alpha’s Quant Rating on Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals: Creating Next-Generation Treatments In Acromegaly
- Crinetics Pharmaceuticals: Paltusotine Phase 3 Data Presented At ENDO
- Crinetics Pharmaceuticals announces proposed public offering of common stock
- Crinetics rated Outperform at Oppenheimer on upcoming Phase 3 data
For further details see:
Crinetics Pharmaceuticals prices $350.0 million upsized stock offering